Back
Halozyme Therapeutics, Inc. Vs. American Public Education, Inc. Industry Stock Comparison
Buy
53
HALO
Halozyme Therapeutics, Inc.
Last Price:
$64.49
Seasonality Move:
2.4%
Buy
90
APEI
American Public Education, Inc.
Last Price:
$57.56
Seasonality Move:
2.53%
Buy
53
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Halozyme Therapeutics, Inc. [HALO] share price is $64.49. The Score for HALO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
90
American Public Education, Inc. (APEI)
is a Buy
Is American Public Education, Inc. a Buy, Sell or Hold?
-
The current American Public Education, Inc. [APEI] share price is $57.66. The Score for APEI is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
-
APEI is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
HALO Stock Price Chart
What is Halozyme Therapeutics, Inc.'s stock price today?
-
The Halozyme Therapeutics, Inc. share price today is $64.49Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing slight selling pressure.
APEI Stock Price Chart
What is American Public Education, Inc.'s stock price today?
-
The American Public Education, Inc. share price today is $57.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APEI is experiencing buying pressure, which is a positive indicator for future bullish movement.
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.64 | Sell |
| Relative Strength Index (14 RSI): | 44.98 | Sell |
| Chaikin Money Flow: | -209098 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.71 - 67.91) | Sell |
| Bollinger Bands (100): | (64.52 - 74.08) | Sell |
APEI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.1 | Buy |
| Relative Strength Index (14 RSI): | 69.18 | Buy |
| Chaikin Money Flow: | 137320 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.94 - 57.4) | Buy |
| Bollinger Bands (100): | (35.21 - 49.39) | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.36 | Buy |
| 20-day SMA: | 64.33 | Buy |
| 50-day SMA: | 69.87 | Sell |
| 200-day SMA: | 67.31 | Sell |
| 8-day EMA: | 63.91 | Buy |
| 20-day EMA: | 64.96 | Sell |
| 50-day EMA: | 67.58 | Sell |
| 200-day EMA: | 66.64 | Sell |
APEI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.24 | Buy |
| 20-day SMA: | 53.74 | Buy |
| 50-day SMA: | 47.86 | Buy |
| 200-day SMA: | 37.49 | Buy |
| 8-day EMA: | 56.78 | Buy |
| 20-day EMA: | 54.09 | Buy |
| 50-day EMA: | 49.05 | Buy |
| 200-day EMA: | 38.69 | Buy |
Halozyme Therapeutics, Inc. Earnings Growth & HALO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.03 per share, an increase this year of $1.46 per share, and an increase next year of $1.83 per share.
American Public Education, Inc. Earnings Growth & APEI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.32 per share, an increase this year of $1.00 per share, and an increase next year of $0.88 per share.
Halozyme Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
American Public Education, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||